BioSpace News Archive

Drug Development

Brickell Biotech Announces Presentation of US Phase 3 Open-Label Long-Term Safety Study Results for Sofpironium Bromide Gel at the Late-Breaking Research Program during American Academy of Dermatology’s 2021 VMX

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that results from the US Phase 3

April 16, 2021
·
5 min read
Policy

/R E P E A T -- Notice to the media - COVID-19 Update (April 16, 2021) - The Prime Minister, Ministers and Government of Canada officials to hold a news conference on coronavirus disease/

The Prime Minister, Ministers and Government of Canada officials will hold a news conference to provide an update on coronavirus disease (COVID-19). Date April 16, 2021 Time 11:45 AM (EDT) Location Sir John A Macdonald Building, Room 200 144 Wellington Street, Ottawa, Ontario

April 16, 2021
·
1 min read
Pharm Country

AIkido Pharma Notes Advancement in Radiopharmaceutical Research

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conducted by a leading global pharmaceutical company. The report provides strong indications for analogous success in similar technology the Company is helping to develop.

April 16, 2021
·
3 min read
BioCapital

Studies Suggest People with Blood Cancers May Not Be Optimally Protected after COVID-19 Vaccination

Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer

April 16, 2021
·
6 min read
Business

Oregon Oncology Specialists Integrate AI-screening Solution VIPER™ Into Network to Expand Patient Access to Clinical Trials

Deep Lens and Oregon Oncology Specialists today announced a strategic collaboration that will integrate Deep Lens’ artificial-intelligence (AI)-based clinical trial screening platform, VIPER™, into their community oncology practice network. VIPER uses proprietary cloud-based technology to facilitate, triage and accelerate the clinical trial recruitment process.

April 16, 2021
·
3 min read
Pharm Country

Portage Biotech Announces Voluntary Delisting from the Canadian Securities Exchange

Common shares will be consolidated on the Nasdaq exchange where shareholders can continue trading under the symbol “PRTG”

April 16, 2021
·
2 min read
Raystation In Clinical Use At Yamagata Carbon Ion Therapy Center

RaySearch Laboratories AB (publ) announces that the new carbon ion therapy center at Yamagata University Hospital in Northern Japan , has treated its first patients using the RayStation®* treatment planning system in combination with Toshiba’s treatment delivery system.

April 16, 2021
·
4 min read
Policy

Advisory - Muscle-relaxant OrfenAce 100 mg tablets recalled because of nitrosamine impurity

Issue SteriMax Inc. is recalling OrfenAce 100 mg tablets after testing identified a nitrosamine impurity above what is considered acceptable if the drug were to be taken over a lifetime.

April 16, 2021
·
3 min read
Pharm Country

St. Luke’s Provides Treatment for COVID ‘Long Haulers’

St. Luke’s is pleased to introduce its new COVID Recovery Clinic, a program dedicated to the treatment of post-COVID-19 patients with lingering symptoms.

April 16, 2021
·
2 min read
Bio NC

Solution Needed to Address Increase in Vaccine Hesitancy for Medical, Religious, Philosophical Reasons Fueled by Johnson & Johnson COVID Vaccine Pause

While various federal agencies recommend a pause in administering Johnson & Johnson’s single-dose COVID-19 vaccine news outlets are reporting on the likelihood of it fueling an increase in vaccine hesitancy

April 16, 2021
·
2 min read